DCGI greets serum institute of India for phase 2 and 3 human trials of the Oxford COVID-19 candidate vaccine

Businsess Insider India has updated its privacy and cookie policy. We use cookies to ensure that we are offering you the most productive fun on our website. If you continue without converting your settings, we will assume that you are satisfied with obtaining all cookies on the Businsess Insider India website. However, you can replace your cookie settings at any time by clicking on our cookie policy at any time. You can also check our privacy policy

Edition

Edition

Leave a Comment

Your email address will not be published. Required fields are marked *